The estimated Net Worth of Timothy J. Richmond is at least $43.5 Milhão dollars as of 1 March 2024. Mr. Richmond owns over 75,680 units of Abbvie Inc stock worth over $2,692,542 and over the last 12 years he sold ABBV stock worth over $37,457,973. In addition, he makes $3,302,520 as Chief Human Resource Officer e Executive Vice President at Abbvie Inc.
Timothy has made over 19 trades of the Abbvie Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 75,680 units of ABBV stock worth $13,415,794 on 1 March 2024.
The largest trade he's ever made was exercising 87,040 units of Abbvie Inc stock on 18 December 2017 worth over $3,122,995. On average, Timothy trades about 14,639 units every 99 days since 2013. As of 1 March 2024 he still owns at least 13,837 units of Abbvie Inc stock.
You can see the complete history of Mr. Richmond stock trades at the bottom of the page.
Timothy J. Richmond is the Chief Human Resource Officer, Executive Vice President of the Company. He served as Senior Vice President, Human Resources from 2013 to 2018. Mr. Richmond served as Abbott’s Divisional Vice President of Compensation & Benefits from 2008 to 2012, as Group Vice President of Talent and Rewards from 2007 to 2008, and as Divisional Vice President of Talent Acquisition from 2006 to 2007. Mr. Richmond joined Abbott in 2006.
As the Chief Human Resource Officer e Executive Vice President of Abbvie Inc, the total compensation of Timothy Richmond at Abbvie Inc is $3,302,520. There are 9 executives at Abbvie Inc getting paid more, with Richard Gonzalez having the highest compensation of $21,610,600.
Timothy Richmond is 52, he's been the Chief Human Resource Officer e Executive Vice President of Abbvie Inc since 2018. There are 23 older and 8 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.
Timothy's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell, eGlenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: